Submitted by Anonymous (not verified) on 1 August 2023 - 8:08
Human medicines European public assessment report (EPAR): Ofev, nintedanib, Idiopathic Pulmonary Fibrosis, Date of authorisation: 14/01/2015, Revision: 24, Status: Authorised
Source: